About: Analysis of pyridinium aldoximes - a chromatographic approach     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Pyridinium aldoximes are used as antidotes to organophosphorus cholinesterase inhibitors. All pyridinium aldoximes (oximes) are highly polar quaternary ammonium compounds showing low to minimal blood-brain-barrier (BBB) penetration. Oximes are separated using reversed-phase (RP) HPLC methods and/or thin-layer chromatography (TLC). The chemical structures, elementary compositions, molecular sizes and the calculated logP values of several mono- and bis-pyridinium aldoximes are given. Chromatographic and electrophoretic analyses of oximes are detailed, including the stationary and mobile phase composition and the mode of detection. Degradation pathways and products are also discussed. To characterize oximes lipophilicity/hydrophilicity an in silico method was used and expanded as to describe organophosphorus compound adducts with several pyridinium aldoximes.
  • Pyridinium aldoximes are used as antidotes to organophosphorus cholinesterase inhibitors. All pyridinium aldoximes (oximes) are highly polar quaternary ammonium compounds showing low to minimal blood-brain-barrier (BBB) penetration. Oximes are separated using reversed-phase (RP) HPLC methods and/or thin-layer chromatography (TLC). The chemical structures, elementary compositions, molecular sizes and the calculated logP values of several mono- and bis-pyridinium aldoximes are given. Chromatographic and electrophoretic analyses of oximes are detailed, including the stationary and mobile phase composition and the mode of detection. Degradation pathways and products are also discussed. To characterize oximes lipophilicity/hydrophilicity an in silico method was used and expanded as to describe organophosphorus compound adducts with several pyridinium aldoximes. (en)
  • Pyridinium aldoximy jsou užívány jako antidota organofosforových inhibitorů cholinesteráz. Všechny pyridiniové aldoximy (oximy) jsou vysoce polární kvartérní amoniové sloučeniny prokazující nízkou minimální blood-brain-barrier (BBB) průchodnost. Oximy jsou separovány užitím HPLC na reverzní fázi (RP) a/či tenkovrstevnou chromatografií (TLC). Chemická struktura, prvkové složení, molekulová velikost a kalkulované hodnoty logP některých mono- a bis-pyridiniových aldoximů jsou dány. Chromatografické a elektroforetické analýzy oximů jsou diskutovány, včetně složení stacionárních a mobilních fází a módů detekce. Degradační cesty a produkty jsou rovněž iskutovány. Za účelem charakterizace lipofility/hydrofility byla užita in silico metoda a rozšířena na popis aductů organofosforových součenin s některými pyridiniovými sloučeninami. (cs)
Title
  • Analysis of pyridinium aldoximes - a chromatographic approach
  • Analýza pyridiniových aldoximů - chromatografický přístup. (cs)
  • Analysis of pyridinium aldoximes - a chromatographic approach (en)
skos:prefLabel
  • Analysis of pyridinium aldoximes - a chromatographic approach
  • Analýza pyridiniových aldoximů - chromatografický přístup. (cs)
  • Analysis of pyridinium aldoximes - a chromatographic approach (en)
skos:notation
  • RIV/60162694:G44__/08:00001929!RIV09-GA0-G44_____
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(GP305/07/P162)
http://linked.open...iv/cisloPeriodika
  • 23
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 355872
http://linked.open...ai/riv/idVysledku
  • RIV/60162694:G44__/08:00001929
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Pyridinium aldoximes; lipophilicity; chromatography; blood-brain-barrier penetration HPLC; blood (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • AE - Stát Spojené arabské emiráty
http://linked.open...ontrolniKodProRIV
  • [1168CED2B404]
http://linked.open...i/riv/nazevZdroje
  • Current Medicinal Chemistry
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 15
http://linked.open...iv/tvurceVysledku
  • Kuča, Kamil
  • Kalasz, H.
  • Tekes, K.
  • Csermely, T.
  • Darvas, F.
  • Ludanyi, K.
  • Mudhafar, A. A.
  • Petroianu, G.
http://linked.open...ain/vavai/riv/wos
  • 000260033600009
issn
  • 0929-8673
number of pages
http://localhost/t...ganizacniJednotka
  • G44
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.116 as of Feb 22 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of Feb 22 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 81 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software